Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ARCH Healthcare Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 2
Lead investments 0
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Life Science
  • Pharmaceutical
Summary

The usual things for fund are deals in the range of 50 - 100 millions dollars. The high activity for fund was in 2010. The fund is constantly included in less than 2 deals per year.

The typical case for the fund is to invest in rounds with more than 10 participants. Despite the ARCH Healthcare Fund, startups are often financed by Vertex Ventures HC, Vertex Ventures, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Windham Venture Partners, Vertex Ventures HC, Vertex Ventures. In the next rounds fund is usually obtained by Kohlberg Kravis Roberts.

The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Life Science, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Earlens Corporation, Arbor Pharmaceuticals.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beyond Black Berlin, Berlin, Germany
CG Health Ventures Barcelona, Catalonia, Spain
Chuanggu Capital Anhui, China, Hefei
Citizens Bank Providence, Rhode Island, United States
Cypress Point Partners Houston, Texas, United States
Deerfield Management New York, New York, United States
Devenish Nutrition Fairmont, Minnesota, United States
Hengqin Xiaozhong Youxuan Guquan Touzi China, Guangdong, Zhuhai
HP Ventures Group Chicago, Illinois, United States
Inter Invest Capital France, Ile-de-France, Paris
International Real Returns -
MCube8 -
Moffu Labs -
NIH Surgery -
Print Marketing -
Shanghai SIIC Fund Management China, Shanghai
The Arena Capital China, Shanghai
Tugboat -
World Gold Council England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Arbor Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$34M11 Nov 2010 Atlanta, Georgia, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ARCH Healthcare Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 34M
Peak activity year 2010
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Arbor Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$34M11 Nov 2010 Atlanta, Georgia, United States
Crunchbase icon

Content report

The following text will be sent to our editors: